Is Apple wasting its time? Valencell thinks so

Rumors abound that companies including Apple are looking to crack noninvasive glucose tracking, which would let people test their blood sugar without breaking the skin – but according to Valencell, which licences biometric sensor tech to Samsung, Sony and other big companies, it’s a nonstarter.

“It is completely impossible to have a truly noninvasive glucose monitor,” Valencell CEO Steven LeBoeuf told Wareable. Right now, invasive techniques can tell diabetics what insulin dosage they need by measuring their blood and interstitial fluid. This can be done by pricking the skin for blood, or tracking interstitial fluid just beneath the surface, as Dexcom’s devices do. Read More